Nurse Practitioner Program year 2024 Reported 2023–2024 Source: CMS Open Payments, 2026 publication

Roni Gray

Nurse Practitioner, Family Omaha, NE Nurse Practitioner

NPI 1952445702 CMS profile 10609439

7261 Mercy Rd, Omaha, NE 68124

Open in the dashboard

General payments

$4,482

19 records reported · program years 2023–2024

Research payments

$2,046

Paid to them · 14 records reported · program years 2023–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Roni Gray of Omaha, NE is reported in the CMS Open Payments database as having received $4,482 across 19 general payments and $2,046 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $1,522 9
2024 Research $2,046 14
2023 General $2,960 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Roni Gray
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Roni Gray were reported at $0. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Roni Gray Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $0 $124 $35–$379 $132
2022 $0 $141 $44–$430 $149
2023 $2,960 $154 $49–$476 $160
2024 $1,522 $165 $51–$504 $164
2025 $0 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2023–2024
  1. Moderna TX, Inc. $2,960 10 payments
  2. AstraZeneca Pharmaceuticals LP $1,522 9 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2024
  1. Travel and Lodging $3,219 11 payments
  2. Food and Beverage $1,263 8 payments
Research payments came from Research payments · program years 2023–2024
  1. Sanofi Pasteur Inc. $2,046 14 payments

Records

33 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Nebraska

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record